Hochschulschrift
Impact of graft invariant natural killer T cells on early cytomegalovirus reactivation following allogeneic hematopoietic cell transplantation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
21 cm
- Extent
-
83 Seiten
- Language
-
Englisch
- Notes
-
1 Illustration, Diagramme
Eberhard Karls Universität Tübingen, Dissertation, 2020
- Event
-
Veröffentlichung
- (where)
-
Tübingen
- (when)
-
2020
- Creator
- Contributor
-
Eberhard Karls Universität Tübingen
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.03.2025, 12:02 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Schneidawind, Dominik
- Eberhard Karls Universität Tübingen
Time of origin
- 2020
Other Objects (12)
Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation
Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantation
Improving safety of preemptive therapy with oral valganciclovir for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
Reconstitution of Interleukin-17-producing T helper cells after allogeneic hematopoietic cell transplantation
Allogeneic hematopoietic stem cell transplantation for congenital immune dysregulatory disorders
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation
Pre-emptive allogeneic hematopoietic stem cell transplantation in ataxia telangiectasia
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Real-world experience with letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation: a multi-centre observational study
Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation
Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantation
Improving safety of preemptive therapy with oral valganciclovir for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
Reconstitution of Interleukin-17-producing T helper cells after allogeneic hematopoietic cell transplantation
Allogeneic hematopoietic stem cell transplantation for congenital immune dysregulatory disorders
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation
Pre-emptive allogeneic hematopoietic stem cell transplantation in ataxia telangiectasia
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Real-world experience with letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation: a multi-centre observational study
Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation
Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantation
Improving safety of preemptive therapy with oral valganciclovir for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
Reconstitution of Interleukin-17-producing T helper cells after allogeneic hematopoietic cell transplantation
Allogeneic hematopoietic stem cell transplantation for congenital immune dysregulatory disorders
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation
Pre-emptive allogeneic hematopoietic stem cell transplantation in ataxia telangiectasia
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review